Tag Archive for: Japan

Stomach Cancer Screening | How Asian and Latinx Patients Can Self-Advocate

Stomach Cancer Screening | How Asian and Latinx Patients Can Self-Advocate from Patient Empowerment Network on Vimeo.

How can Asian and Latinx patients self-advocate for gastric cancer screening? Expert Dr. Joo Ha Hwang from Stanford Medicine shares advice for how patients can discuss gastric cancer screening with their provider and how providers should be engaging with patients for better care.

[ACT]IVATION TIP

“…especially if you come from Korea, Japan, where they actually have instituted national screening, with endoscopy, we actually have U.S. guidelines that state that if you come from a country whose guidelines state you should have endoscopy, then you should also have endoscopy, we should be following your home of origins guidelines for you and so, those patients should also have endoscopy.”

See More from [ACT]IVATED Gastric Cancer

Related Resources:

How Biomarkers Might Impact Future Stomach Cancer Care

How Biomarkers Might Impact Future Stomach Cancer Care

What Are Key Risk Factors for Stomach Cancer?

What Are Key Risk Factors for Stomach Cancer?

Potential Impact of Artificial Intelligence on Stomach Cancer Detection and CarePotential Impact of Artificial Intelligence on Stomach Cancer Detection and Care

Transcript:

Lisa Hatfield:

So in the United States, we do have many people from the Asian and Hispanic communities who may be at higher risk for gastric cancer, do you suggest that they talk to their provider about getting screened? And how might they phrase that question? Can I get screened for the H. pylorI? So if you had a patient who wanted to be screened or is interested in getting screened, how might they approach their provider in asking for the screening for gastric cancer or H. pylori?

Dr. Joo Ha Hwang:

I think the first step is to get tested for H. pylori, and pretty much, everyone who is, an immigrant to the U.S. is at much higher risk for having H. pylori, in the past, we used to say that the people from Asia, immigrants from Asia had an 80 percent risk of having H. pylori, from Mexico, it was more like around 60 percent, United States, it was in the 20 to 30 percent, it’s probably less than that now.

So worldwide, prevalence of H. pylori is certainly going down but again, providers should know this is something that is taught in medical school, is areas that are, endemic with H. pylori and providers should also know that, H. pylori is a carcinogen, and so if a patient just comes up in and says I’m worried about having H. pylori, I come from a high-risk population, it really shouldn’t be difficult to get tested for H. pylori, furthermore, if they have any symptoms, especially any epigastric pain what we call dyspepsia that should also trigger the provider to go ahead and test for H. pylori, because that’s part of the algorithm. So I think that all of these, it shouldn’t be difficult to engage a provider on that particular issue.

Lisa Hatfield:

So it is okay and appropriate for a patient to approach their provider and ask that question? So I appreciate that.

Dr. Joo Ha Hwang:

I think it’s important and I think that patients need to be their own advocates, because I have heard of instances where providers have been reluctant and in certain systems they’re discouraged from further testing, because it’s a capitated system. I think H. pylori testing is not that difficult, sometimes if patients want endoscopy, it can be, more challenging but again, especially if you come from Korea, Japan, where they actually have instituted national screening, with endoscopy, we actually have U.S. guidelines that state that if you come from a country whose guidelines state you should have endoscopy, then you should also have endoscopy, we should be following your home of origins guidelines for you and so, those patients should also have endoscopy.

But the challenge with that is that they’re going to end up paying for it, because it’s not typically covered by insurance or it’s not fully covered by insurance so you’d probably have to pay a copay, for something like that at this time.

Lisa Hatfield:

I have a friend who’s dealing with her father who lives in Korea, she’s from Korea, has been here about two, five years. He has stomach cancer. So we’ve been having this discussion, and that’s why I thought I’d ask that last question. She said she sometimes is afraid to approach her provider…

Dr. Joo Ha Hwang:

If you’re afraid to approach your provider, you need a different provider.

Lisa Hatfield:

Well, that’s a good suggestion too.

Dr. Joo Ha Hwang:

No, no. We’re supposed to work with you and listen to you and again, I go around and give a lot of talks to patient groups, and I like engaging in these types of activities, because I think the more information patients have, the more that they can talk with their physicians, and oftentimes patients know more than their physicians do, because they’ve done a lot more research. And hopefully you have a physician with some hubris who will listen to the patient and if they don’t know, they’ll kind of look things up, so yeah.

Lisa Hatfield:

Yeah. I appreciate that, thank you.

Dr. Joo Ha Hwang:

My pleasure.


Share Your Feedback

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes?

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes? from Patient Empowerment Network on Vimeo.

Are there treatments and lifestyle changes that can reduce stomach cancer risk? Expert Dr. Joo Ha Hwang from Stanford Medicine discusses key risk factors of gastric cancer, incidence rates in some population groups, and recommended diet modifications to reduce risk.

[ACT]IVATION TIP

“…for anybody, not just, if you’re Asian or Latinx, talk to your physician about a healthy diet, because what I basically talk to my patients about is I counsel them on minimizing salt intake increasing fiber, higher intake of fresh fruits and vegetables, a well-balanced diet. I don’t think you need to go to an extreme, there are no supplements that you need to take that will protect you from developing gastric cancer, probiotics really aren’t of benefit either.”

See More from [ACT]IVATED Gastric Cancer

Related Resources:

How Biomarkers Might Impact Future Stomach Cancer Care

How Biomarkers Might Impact Future Stomach Cancer Care

What Are Key Risk Factors for Stomach Cancer?

What Are Key Risk Factors for Stomach Cancer?

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

Transcript:

Lisa Hatfield:

So you mentioned there is a treatment for H. pylori, does that significantly reduce the risk of gastric cancer then, if that’s treated?

Dr. Joo Ha Hwang:

Yes. It really depends on when you catch it. So if you catch H. pylori before it’s done, its damage to the stomach, it essentially brings your risk of gastric cancer back down to the baseline population, which is very, very low. If you catch H. pylori infection after it’s caused problems, you still decrease the risk, you kind of flatten the curve but you’re still at increased risk, if the damage to the stomach has already been done and you’ve already progressed onto intestinal metaplasia.

Lisa Hatfield:

Dr. Hwang, how do diet and lifestyle contribute to the incidence of gastric cancer in Asian and Latinx populations?

Dr. Joo Ha Hwang:

The main reason the diet affects, the risk of gastric cancer, is the salt content, to the best, that we know, and so we know that high salt content, for some reason increases your risk of gastric cancer, we think that maybe salts, somehow interacts with the mucosal barrier in the stomach and allows for H. pylori to become more invasive, we don’t know the specific mechanism for that but there was a recent study that came out of England that showed that if you added salt to your diet on a regular basis, that you increased your risk of developing gastric cancer by about 40 percent. Now, to put that into context, compared to the baseline population, if you have H. pylori infection, you increase your risk of developing gastric cancer by 2 to 300 percent.

And if you come from Korea or Japan, your risk of developing gastric cancer is probably somewhere between 8 to 1200 percent higher than the baseline population. So a 40 percent increase because of diet alone is a modest increase, compared to H. pylori infection and to some degree, your ethnicity. So that’s really both diet and lifestyle. There’s some data also that suggests, processed meats also increase your risk of gastric cancer, it’s always hard to study diet and its role in developing any type of cancer, because getting that data, specific enough is very difficult, but it makes a lot of sense since your stomach is basically the first thing that that food sees and we know that food can be somewhat toxic. On the flip side, things that we know to be healthy are the common sense stuff like fresh fruits, fresh vegetables.

We know that that is somewhat protective. And so how I counsel my patients and my activation code for this would be that for anybody, not just, if you’re Asian or Latinx, talk to your physician about a healthy diet, because what I basically talk to my patients about is I counsel them on minimizing salt intake increasing fiber, higher intake of fresh fruits and vegetables, a well-balanced diet. I don’t think you need to go to an extreme, there are no supplements that you need to take that will protect you from developing gastric cancer, probiotics really aren’t of benefit either. So in terms of diet and lifestyle, I think that those are just the main take-home points.


Share Your Feedback

How Biomarkers Might Impact Future Stomach Cancer Care?

How Biomarkers Might Impact Future Stomach Cancer Care from Patient Empowerment Network on Vimeo.

How might biomarkers impact the future of stomach cancer care? Expert Dr. Joo Ha Hwang from Stanford Medicine discusses the status of biomarkers in gastric cancer research and how gastric cancer screening and health outcomes in the U.S. compare to the rest of the world. 

See More from [ACT]IVATED Gastric Cancer

Related Resources:

What Are Key Risk Factors for Stomach Cancer?

What Are Key Risk Factors for Stomach Cancer?

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes?

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes?

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

Transcript:

Lisa Hatfield:

Dr. Hwang, can you speak to emerging biomarkers for early gastric cancer that have shown the most promise in your research? And how might these biomarkers influence future therapeutic strategies and outcomes for gastric cancer patients?

Dr. Joo Ha Hwang:

Yeah, it’s still very, very early days for biomarkers in the field of gastric cancer. Unlike other more prevalent tumors in the United States, and this has to go towards funding for research. Gastric cancer research has been fairly underfunded in the United States. The incidence of gastric cancer is not low, actually. There’s a lot more research in esophageal cancer and Barrett’s esophagus, but actually the prevalence or the incidence of esophageal cancer is much lower than stomach cancer.

So, fortunately the funding environment is slowly starting to change. There are active studies ongoing, both in the United States and abroad on looking at biomarkers. But I would say it’s too preliminary to even suggest that there are any specific biomarkers out there that might help to detect early gastric cancer.

And that’s either by tissue biopsy or anything that might be in the blood. But it will come, I mean, it’s coming for other diseases like colon cancer. So I’m confident that eventually we’ll see biomarkers come for detection of early gastric cancer, and we really need these biomarkers, or we need to be doing something because right now outcomes in the United States for gastric cancer are some of the worst in the world because we really don’t do anything for gastric cancer.

For example, the five-year overall survival for gastric cancer, if you’re diagnosed to it within the U.S., is only 30 percent. But if you’re in Korea, Japan, the overall five-year survival is somewhere close to 70 percent. And the single reason for that is the stage of diagnosis. Japan and Korea have screening programs to detect early gastric cancer, and in the United States we really don’t do anything. And so there’s a lot of ground that can be made up. And what’s frustrating for me is that this is a very curable cancer. And there are pre-malignant conditions that we know of that we can survey for, but right now the general policy in the United States is don’t do anything. So we really need to change that.


Share Your Feedback